11th stakeholder forum on the pharmacovigilance legislation

• Date:
  Thursday, 21 September 2017, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

This forum brings together regulators with patients, healthcare professionals and industry, to take stock of what we have achieved and what needs to be the focus over the coming years.

Documents

Agenda – Eleventh stakeholder forum on the pharmacovigilance legislation

AdoptedReference Number: EMA/303132/2017

Presentation - Future opportunities for pharmacovigilance (à. Spooner, HPRA and PRAC)

Presentation - How patients and healthcare professionals can be involved in public hearings (J. Garcia Burgos, EMA)

Presentation - Pharmacovigilance Risk Assessment Committee - Five years of operation (J. Raine, PRAC)

Presentation - Strengthening collaborations for operating pharmacovigilance in Europe Joint Action (L. Loughlin, MHRA)

Presentation - EudraVigilance – new functionalities and EudraVigilance access policy (patient access) (S. Brosch, EMA)

Presentation - Patient Registries Initiative Lessons learned from the recent workshops (X. Kurz, EMA)

Presentation - Signal management process (G. Genov, EMA)

Presentation - Learnings & next steps for EMSP as initiator and driver (C.Thalheim, J.Hlavacova)

Multimedia

Session 1

 

Session 2

Session 3